|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA03030018
|
11-Dehydro-13,14-dihydro-15-keto-thromboxane B2
|
9S-hydroxy-11,15-dioxo-thromboxa-5Z-en-1-oic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219891
|
|
LMFA03030018
|
11-Dehydro-13,14-dihydro-15-keto-thromboxane B2
|
9S-hydroxy-11,15-dioxo-thromboxa-5Z-en-1-oic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219891
|
|
LMFA03010265
|
alpha-tetranor 15keto-13,14-dihydro PGF3alpha
|
9S,11R-dihydroxy-15-keto-2,3,4,5-tetranorprosta-17Z-enoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010265
|
alpha-tetranor 15keto-13,14-dihydro PGF3alpha
|
9S,11R-dihydroxy-15-keto-2,3,4,5-tetranorprosta-17Z-enoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010265
|
alpha-tetranor 15keto-13,14-dihydro PGF3alpha
|
9S,11R-dihydroxy-15-keto-2,3,4,5-tetranorprosta-17Z-enoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010265
|
alpha-tetranor 15keto-13,14-dihydro PGF3alpha
|
9S,11R-dihydroxy-15-keto-2,3,4,5-tetranorprosta-17Z-enoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010265
|
alpha-tetranor 15keto-13,14-dihydro PGF3alpha
|
9S,11R-dihydroxy-15-keto-2,3,4,5-tetranorprosta-17Z-enoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA01030524
|
5,9-octadecadiynoic acid
|
5,9-octadecadiynoic acid
|
FA 18:4
|
C18H28O2
|
276.208930
|
|
LMFA01030524
|
5,9-octadecadiynoic acid
|
5,9-octadecadiynoic acid
|
FA 18:4
|
C18H28O2
|
276.208930
|
|
LMFA02000222
|
9,10,18-TriHOME(12)
|
9,10,18-trihydroxy-12-octadecenoic acid
|
FA 18:1;O3
|
C18H34O5
|
330.240626
|
|
LMFA02000222
|
9,10,18-TriHOME(12)
|
9,10,18-trihydroxy-12-octadecenoic acid
|
FA 18:1;O3
|
C18H34O5
|
330.240626
|
|
LMFA02000222
|
9,10,18-TriHOME(12)
|
9,10,18-trihydroxy-12-octadecenoic acid
|
FA 18:1;O3
|
C18H34O5
|
330.240626
|
|
LMFA01030484
|
8-heptadecynoic acid
|
8-heptadecynoic acid
|
FA 17:2
|
C17H30O2
|
266.224581
|
|
LMFA03060060
|
9-oxo-5E,7Z,11Z,14Z-eicosatetraenoic acid
|
9-oxo-5E,7Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:5;O
|
C20H30O3
|
318.219496
|
|
LMFA03060060
|
9-oxo-5E,7Z,11Z,14Z-eicosatetraenoic acid
|
9-oxo-5E,7Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:5;O
|
C20H30O3
|
318.219496
|
|
LMFA03060060
|
9-oxo-5E,7Z,11Z,14Z-eicosatetraenoic acid
|
9-oxo-5E,7Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:5;O
|
C20H30O3
|
318.219496
|
|
LMFA01050307
|
Agonandric acid
|
8-hydroxy-11E-octadecen-9-ynoic acid
|
FA 18:3;O
|
C18H30O3
|
294.219496
|
|
LMFA01050307
|
Agonandric acid
|
8-hydroxy-11E-octadecen-9-ynoic acid
|
FA 18:3;O
|
C18H30O3
|
294.219496
|
|
LMFA01050307
|
Agonandric acid
|
8-hydroxy-11E-octadecen-9-ynoic acid
|
FA 18:3;O
|
C18H30O3
|
294.219496
|
|
LMFA03030019
|
15-Keto-13,14-dihydro TXB2
|
9S,11-Dihydroxy-15-oxothrombox-5Z-en-1-oic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03030019
|
15-Keto-13,14-dihydro TXB2
|
9S,11-Dihydroxy-15-oxothrombox-5Z-en-1-oic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03030019
|
15-Keto-13,14-dihydro TXB2
|
9S,11-Dihydroxy-15-oxothrombox-5Z-en-1-oic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03030019
|
15-Keto-13,14-dihydro TXB2
|
9S,11-Dihydroxy-15-oxothrombox-5Z-en-1-oic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03030019
|
15-Keto-13,14-dihydro TXB2
|
9S,11-Dihydroxy-15-oxothrombox-5Z-en-1-oic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010266
|
5,6-dihydro-2,3-dinor-PGF3alpha
|
7R,9S,13S-trihydr-dinor-prosta- 11,15-dienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA03010267
|
13,14-dihydro-20-hydroxy-15-oxoprostaglandin F2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prostenoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010267
|
13,14-dihydro-20-hydroxy-15-oxoprostaglandin F2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prostenoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010267
|
13,14-dihydro-20-hydroxy-15-oxoprostaglandin F2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prostenoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010267
|
13,14-dihydro-20-hydroxy-15-oxoprostaglandin F2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prostenoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010267
|
13,14-dihydro-20-hydroxy-15-oxoprostaglandin F2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prostenoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010268
|
13,14-dihydro-20-hydroxy-15-oxo-20-carboxy-PGF2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prosten-1,20dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA03010268
|
13,14-dihydro-20-hydroxy-15-oxo-20-carboxy-PGF2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prosten-1,20dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA03010268
|
13,14-dihydro-20-hydroxy-15-oxo-20-carboxy-PGF2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prosten-1,20dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA03010268
|
13,14-dihydro-20-hydroxy-15-oxo-20-carboxy-PGF2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prosten-1,20dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA03010268
|
13,14-dihydro-20-hydroxy-15-oxo-20-carboxy-PGF2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prosten-1,20dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA03010268
|
13,14-dihydro-20-hydroxy-15-oxo-20-carboxy-PGF2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prosten-1,20dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA01100045
|
2-Amino-3-hydroxypropanoic acid
|
2-Amino-3-hydroxypropanoic acid
|
|
C3H7NO3
|
105.042594
|
|
LMFA01100045
|
2-Amino-3-hydroxypropanoic acid
|
2-Amino-3-hydroxypropanoic acid
|
|
C3H7NO3
|
105.042594
|
|
LMFA01030711
|
8S-hydroxy-2-Decene-4,6-diynoic acid
|
8S-hydroxy-2-Decene-4,6-diynoic acid
|
FA 10:5;O
|
C10H10O3
|
178.062995
|
|
LMFA01030711
|
8S-hydroxy-2-Decene-4,6-diynoic acid
|
8S-hydroxy-2-Decene-4,6-diynoic acid
|
FA 10:5;O
|
C10H10O3
|
178.062995
|
|
LMFA03010269
|
19R-hydroxy-PGB1
|
9-oxo-15S,19R-dihydroxy-8(12),13E-prostadienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010269
|
19R-hydroxy-PGB1
|
9-oxo-15S,19R-dihydroxy-8(12),13E-prostadienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010269
|
19R-hydroxy-PGB1
|
9-oxo-15S,19R-dihydroxy-8(12),13E-prostadienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010269
|
19R-hydroxy-PGB1
|
9-oxo-15S,19R-dihydroxy-8(12),13E-prostadienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010269
|
19R-hydroxy-PGB1
|
9-oxo-15S,19R-dihydroxy-8(12),13E-prostadienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010279
|
20-hydroxy Dinor-PGD2
|
2,3-dinor-9S,15S,20-trihydroxy-11-oxo-5Z,13E-prostadienoic acid
|
FA 18:4;O4
|
C18H28O6
|
340.188591
|
|
LMFA03010280
|
13,14-dihydro-15-keto-20-hydroxy 2,3,4,5-tetranor-PGD2
|
2,3,4,5-tetranor-9S,20-trihydroxy-11,15-dioxo-5Z-prostenoic acid
|
FA 16:3;O4
|
C16H26O6
|
314.172940
|
|
LMFA03010285
|
19-hydroxy-tetranor-PGB2
|
9-oxo-15S,19-dihydroxy-8(12),13E-2,3,4,5-tetranor-prostadiienoic acid
|
FA 16:4;O3
|
C16H24O5
|
296.162375
|
|
LMFA03010285
|
19-hydroxy-tetranor-PGB2
|
9-oxo-15S,19-dihydroxy-8(12),13E-2,3,4,5-tetranor-prostadiienoic acid
|
FA 16:4;O3
|
C16H24O5
|
296.162375
|
|
LMFA03010285
|
19-hydroxy-tetranor-PGB2
|
9-oxo-15S,19-dihydroxy-8(12),13E-2,3,4,5-tetranor-prostadiienoic acid
|
FA 16:4;O3
|
C16H24O5
|
296.162375
|